Provenance du réseau au premier degré de Matthew J. Pietras
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 11 | |
| Public Company | Medical Specialties | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthew J. Pietras via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| WUXI APPTEC CO., LTD. | Pharmaceuticals: Major | Chief Investment Officer Director/Board Member Director/Board Member | |
| WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Director/Board Member Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Wuxi New Life Science Investment Ltd.
 Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Wuxi Biologics Holdings Ltd.
 Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong. | Investment Managers | Director of Investments Private Equity Analyst | |
| Boyu Capital Group Management Ltd. | Corporate Officer/Principal | ||
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ANTENGENE CORPORATION LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Juniata College | College/University | Undergraduate Degree | |
| JW (CAYMAN) THERAPEUTICS CO. LTD | Biotechnology | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree | |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Entegra Systems, Inc.
 Entegra Systems, Inc. Information Technology ServicesTechnology Services Entegra Systems, Inc. develops critical intelligence solutions for national security. Its services include customer needs analysis, solution architecture definition, systems engineering, software development, product integration, ontology and data modeling and specialized training. The firm offers solutions for enhanced situational awareness, operational planning, intelligence and geospatial analysis and cyber and intelligence operations. The company was founded by Dean Alan Johnson in June 2005 and is headquartered in Hanover, MD. | Information Technology Services | Corporate Officer/Principal | |
Fujian Herui Gene Technology Co., Ltd.
 Fujian Herui Gene Technology Co., Ltd. BiotechnologyHealth Technology Fujian Herui Gene Technology Co. Ltd. provides biotechnological services. It mainly engages in the medical research & experimental development, biotechnology equipment leasing and medical testing services. The company was founded on August 17, 2017 and is headquartered in Fuzhou, China. | Biotechnology | Director/Board Member | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Corporate Officer/Principal | |
| GAN & LEE PHARMACEUTICALS. | Pharmaceuticals: Major | Director/Board Member | |
| General Atlantic LLC (China) | Investment Managers | Corporate Officer/Principal | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
VaxEquity Ltd.
 VaxEquity Ltd. BiotechnologyHealth Technology VaxEquity Ltd. is a UK biotechnology company founded in 2020 by Professor Robin Shattock, the head of immunology of infection at Imperial College and Morningside. The company is based in Little Chesterford, UK. The British company is developing transformative RNA therapeutics and vaccines using its next-generation self-amplifying RNA platform called SARNA. The platform provides extended duration of protein expression, enabling lower doses to be used for vaccines and higher protein levels to be achieved for therapeutics. VaxEquity is pioneering a next-generation approach by modifying its SARNA to modulate the innate immune response and thereby overcoming current limitations. The flexibility of the company's platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale. | Biotechnology | Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
| VAXXINITY, INC. | Biotechnology | Human Resources Officer | |
| The University of North Carolina at Wilmington | College/University | Undergraduate Degree | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Toronto | College/University | Graduate Degree | |
| Rotman School of Management | College/University | Masters Business Admin | |
Maryland Technology Council
 Maryland Technology Council Miscellaneous Commercial ServicesCommercial Services The Maryland Technology Council functions as a technology trade association. The private company is based in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| VENTYX BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Weill Cornell Medicine | College/University | Doctorate Degree | |
| Universität zu Köln | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 25 |
| Chine | 15 |
| Royaume-Uni | 3 |
| Canada | 3 |
| Hong Kong | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 7 |
| Electronic Technology | 2 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 70 |
| Corporate Officer/Principal | 19 |
| Independent Dir/Board Member | 13 |
| Undergraduate Degree | 8 |
| Chief Tech/Sci/R&D Officer | 8 |
Relations les plus connectées
| Insiders | |
|---|---|
| Edward Hu | 29 |
| Yan Ling Cao | 21 |
| Tyrell J. Rivers | 17 |
| Xiao Meng Tong | 15 |
| Wen Kai Xiang | 13 |
| Zheng Bin Yao | 11 |
| Jörn Drappa | 10 |
| Mitchell Chan | 6 |
| Kate Surdez | 6 |
| Aaron Ren | 5 |
| Carl Solomon | 4 |
| Soraya Madani | 1 |
- Bourse
- Insiders
- Matthew J. Pietras
- Connexions Sociétés
